From: An evaluation of the sonoporation potential of low-boiling point phase-change ultrasound contrast agents in vitro
Conditions
PCCAs (Y/N)
Cycles (#)
PRF (kHz)
Pressure (kPa)
1–4
Y
5, 10, 20, 50
5
125
5–8
300
9–12
600
US only control
N
50
Sham control
NA